Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease

Bibliographic Details
Title: Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease
Authors: M d Mesbah Uddin, Ngoc Quynh H. Nguyen, Bing Yu, Jennifer A. Brody, Akhil Pampana, Tetsushi Nakao, Myriam Fornage, Jan Bressler, Nona Sotoodehnia, Joshua S. Weinstock, Michael C. Honigberg, Daniel Nachun, Romit Bhattacharya, Gabriel K. Griffin, Varuna Chander, Richard A. Gibbs, Jerome I. Rotter, Chunyu Liu, Andrea A. Baccarelli, Daniel I. Chasman, Eric A. Whitsel, Douglas P. Kiel, Joanne M. Murabito, Eric Boerwinkle, Benjamin L. Ebert, Siddhartha Jaiswal, James S. Floyd, Alexander G. Bick, Christie M. Ballantyne, Bruce M. Psaty, Pradeep Natarajan, Karen N. Conneely
Source: Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Publisher Information: Nature Portfolio, 2022.
Publication Year: 2022
Collection: LCC:Science
Subject Terms: Science
More Details: Clonal hematopoiesis, often caused by mutations in DNMT3A and TET2, is associated with blood cancer and coronary artery disease. Here, the authors conduct an epigenome-wide association study, finding that clonal hematopoiesis caused by DNMT3A vs. TET2 mutations has directionally opposing changes in DNA methylation profiles, with both promoting stem cell self-renewal.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2041-1723
Relation: https://doaj.org/toc/2041-1723
DOI: 10.1038/s41467-022-33093-3
Access URL: https://doaj.org/article/c22e81f057bd44ef857ef1b82f628c5a
Accession Number: edsdoj.22e81f057bd44ef857ef1b82f628c5a
Database: Directory of Open Access Journals
More Details
ISSN:20411723
DOI:10.1038/s41467-022-33093-3
Published in:Nature Communications
Language:English